1. Update in antibiotic therapy in intensive care unit: report from the 2019 Nîmes International Symposium.
- Author
-
Leone M, Roberts JA, Bassetti M, Bouglé A, Lavigne JP, Legrand M, Neely M, Paiva JA, Payen D, Rello J, Roger C, Sjövall F, and Jung B
- Subjects
- Administration, Inhalation, Anti-Bacterial Agents administration & dosage, Anti-Bacterial Agents adverse effects, Anti-Bacterial Agents pharmacokinetics, Critical Care, Dose-Response Relationship, Drug, Drug Resistance, Microbial, Drug Resistance, Multiple, Drug Therapy, Combination, Drug Utilization, Drugs, Investigational therapeutic use, Europe, Extracorporeal Membrane Oxygenation, Forecasting, Humans, Kidney Diseases chemically induced, Microbial Sensitivity Tests, Microbiota drug effects, Nebulizers and Vaporizers, Peripheral Nervous System Diseases chemically induced, Population Surveillance, beta-Lactams adverse effects, Anti-Bacterial Agents therapeutic use, Antimicrobial Stewardship, Intensive Care Units statistics & numerical data
- Abstract
The 2019 Nîmes International Symposium in Antibiotic Therapy Optimisation aimed at determining the best approaches of a number of the antibiotic management strategies for critically ill patients. Experts reviewed the latest literature relating to requirements for an optimal antibiotic stewardship program, risks of sub-therapeutic dosing of antibiotics in critically ill patients, persisting issues about efficiency of combination therapy and the value of de-escalation, new perspectives of pharmacokinetics, drug toxicities including collateral damages-associated with antibiotics, the place of nebulisation of antibiotics, management of patients receiving extracorporeal therapies and the place of new antibiotics. In this paper, each of these issues is discussed with key messages presented after a brief review of evidence., (Copyright © 2019. Published by Elsevier Masson SAS.)
- Published
- 2019
- Full Text
- View/download PDF